labetalol has been researched along with oxidopamine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Frame, V; Lathers, CM; Roberts, J; Tumer, N | 1 |
| Endo, J; Ohshika, H; Takemura, H; Tanaka, M | 1 |
| Becker, KJ; Kunze, A; Olmstead, T; Shen, A; Stults, A; Zierath, D | 1 |
4 other study(ies) available for labetalol and oxidopamine
| Article | Year |
|---|---|
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Protection of CGS 10078B against ouabain-induced arrhythmia in the cat.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Blood Pressure; Cats; Dioxins; Female; Heart Rate; Hydroxydopamines; Labetalol; Male; Ouabain; Oxidopamine; Timolol | 1987 |
Potentiation of isoproterenol-induced salivation by labetalol.
Topics: Amylases; Animals; Cyclic AMP; Dose-Response Relationship, Drug; Drug Synergism; Epinephrine; Ethanolamines; Hydroxydopamines; In Vitro Techniques; Isoproterenol; Labetalol; Male; Oxidopamine; Parotid Gland; Potassium; Rats; Rats, Inbred Strains; Reserpine; Salivation | 1982 |
Chemical Sympathectomy, but not Adrenergic Blockade, Improves Stroke Outcome.
Topics: Adrenergic Antagonists; Animals; Behavior, Animal; Brain; C-Reactive Protein; Disease Models, Animal; Infarction, Middle Cerebral Artery; Inflammation Mediators; Labetalol; Male; Motor Activity; Oxidopamine; Rats, Inbred Lew; Recovery of Function; Sympathectomy, Chemical; Sympatholytics; Th1 Cells; Th17 Cells | 2018 |